Cargando…
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series
BACKGROUND: Prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding has been described in immunocompromised coronavirus disease 2019 (COVID-19) patients, resulting in protracted disease and poor outcome. Specific therapy to improve viral clearance and outcome for this group o...
Autores principales: | van Laarhoven, Arjan, Kurver, Lisa, Overheul, Gijs J., Kooistra, Emma J., Abdo, Wilson F., van Crevel, Reinout, Duivenvoorden, Raphaël, Kox, Matthijs, ten Oever, Jaap, Schouten, Jeroen, van de Veerdonk, Frank L., van der Hoeven, Hans, Rahamat-Langendoen, Janette, van Rij, Ronald P., Pickkers, Peter, Netea, Mihai G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452508/ https://www.ncbi.nlm.nih.gov/pubmed/34568856 http://dx.doi.org/10.1016/j.medj.2021.09.003 |
Ejemplares similares
-
SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patients
por: Kurver, Lisa, et al.
Publicado: (2022) -
Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
por: Machiels, Julian D, et al.
Publicado: (2020) -
Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo
por: Koch, Rebecca M., et al.
Publicado: (2017) -
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
por: Varghese, Finny S., et al.
Publicado: (2021) -
A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
por: Kooistra, Emma J., et al.
Publicado: (2021)